Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

What is the response rate for ruxolitinib and azacitidine combination?

See the DrugPatentWatch profile for ruxolitinib

What response rate was reported for the ruxolitinib plus azacitidine combination?

The provided information does not include any clinical response-rate data for the ruxolitinib and azacitidine combination, so I can’t state a specific response rate from it.

Which response rate measure are you looking for (ORR vs CR vs overall survival)?

“Response rate” can mean different endpoints in clinical trials, such as:
- ORR (overall response rate)
- CR (complete response)
- CR/PL (complete response plus platelet recovery)
- hematologic improvement or other composite response definitions

If you tell me the exact study/trial (or the patient population, such as myelodysplastic syndromes, AML, or post-transplant relapse), I can align to the correct endpoint.

Can you share the trial name or source?

If you share the trial identifier (e.g., NCT number) or the text you’re working from, I can extract the reported response rate for ruxolitinib + azacitidine.



Other Questions About Ruxolitinib :

Can you provide the precise date for apotex s ruxolitinib fda submission? Ruxolitinib patent expiration date? When did apotex s ruxolitinib receive fda approval? Ruxolitinib when do patents expire? Is concurrent use of steroids ruxolitinib safe? What is the expected launch date of apotex's ruxolitinib generic? Has apotex s ruxolitinib resubmission been accepted by the fda?